ctrl K

Price Alert

Silexion Therapeutics Ltd... (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

7.20

0.07 (0.98%)

At close: Aug 26, 2025, 3:59 PM

7.26

0.83%

After-hours: Aug 26, 2025, 06:57 PM EDT

Silexion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.19M	4.59M	8.26M	38.94K
Short-Term Investments	35K	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	115.01M
Other Long-Term Assets	53K	30K	30K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	97K	49K	67K	n/a
Total Current Assets	2.25M	4.98M	8.84M	407.8K
Property-Plant & Equipment	560K	247K	464K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	613K	277K	494K	115.01M
Total Assets	2.86M	5.26M	9.33M	115.41M
Account Payables	929K	319K	240K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1M	n/a	n/a	n/a
Other Current Liabilities	790K	407K	256K	348.58K
Total Current Liabilities	3.52M	2.2M	1.61M	348.58K
Long-Term Debt	2.96M	n/a	n/a	n/a
Other Long-Term Liabilities	2.96M	15.06M	14.65M	160.34K
Total Long-Term Liabilities	3.33M	15.12M	14.8M	160.34K
Total Liabilities	6.85M	17.31M	16.41M	508.92K
Total Debt	4.49M	171K	271K	n/a
Common Stock	2K	1K	1K	115M
Retained Earnings	-43.25M	-26.81M	-21.87M	-951.08K
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-3.99M	-15.48M	-10.66M	114.91M
Total Investments	35K	n/a	n/a	115.01M